Synergistic activation of p53-dependent transcription by two cooperating damage recognition pathways.
High level activation of p53-dependent transcription occurs following cellular exposure to genotoxic damaging agents such as UV-C, while ionizing radiation damage does not induce a similarly potent induction of p53-dependent gene expression. Reasoning that one of the major differences between UV-C and ionizing radiation damage is that the latter does not inhibit general transcription, we attempted to reconstitute p53-dependent gene expression in ionizing irradiated cells by co-treatment with selected transcription inhibitors that alone do not activate p53. p53-dependent transcription can be dramatically enhanced by the treatment of ionizing irradiated cells with low doses of DRB, which on its own does not induce p53 activity. The mechanism of ionizing radiation-dependent activation of p53-dependent transcription using DRB is more likely due to inhibition of gene transcription rather than prolonged DNA damage, as the non-genotoxic and general transcription inhibitor Roscovitine also synergistically activates p53 function in ionizing irradiated cells. These results identify two distinct signal transduction pathways that cooperate to fully activate p53-dependent gene expression: one responding to lesions induced by ionizing radiation and the second being a kinase pathway that regulates general RNA Polymerase II activity.
Blaydes
J P
JP
Department of Molecular and Cellular Pathology, Dundee Cancer Research Centre, Ninewells Medical School, University of Dundee, Scotland.
Craig
A L
AL
Wallace
M
M
Ball
H M
HM
Traynor
N J
NJ
Gibbs
N K
NK
Hupp
T R
TR
D000595:Amino Acid Sequence; D018844:Cyclin-Dependent Kinases / Q000037:antagonists & inhibitors / Q000528:radiation effects; D004249:DNA Damage / Q000187:drug effects / Q000502:physiology* / Q000528:radiation effects; D004004:Dichlororibofuranosylbenzimidazole / Q000494:pharmacology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005786:Gene Expression Regulation / Q000528:radiation effects; D006801:Humans; D008545:Melanoma; D008969:Molecular Sequence Data; D010766:Phosphorylation; D011687:Purines / Q000494:pharmacology; D012319:RNA Polymerase II / Q000037:antagonists & inhibitors / Q000235:genetics; D000077546:Roscovitine; D012694:Serine / Q000378:metabolism; D015398:Signal Transduction; D014158:Transcription, Genetic; D014407:Tumor Cells, Cultured; D016159:Tumor Suppressor Protein p53 / Q000235:genetics* / Q000378:metabolism* / Q000528:radiation effects; D014466:Ultraviolet Rays; D014965:X-Rays
D004791:Enzyme Inhibitors; D011687:Purines; D016159:Tumor Suppressor Protein p53; D000077546:Roscovitine; D012694:Serine; D004004:Dichlororibofuranosylbenzimidazole; D018844:Cyclin-Dependent Kinases; D012319:RNA Polymerase II